Call Us: US - +1 845 478 5244 | UK - +44 20 7193 7850 | AUS - +61 2 8005 4826

Organisations Management Service

In today’s competitive environment the reduction of the time taken to reach the market is critical to a product’s and hence the company’s success. The proper conduct of its Regulatory Affairs activities is therefore of considerable economic importance for the company. Inadequate reporting of data may prevent a timely positive evaluation of a marketing application. A new drug may have cost many millions of Euros or dollars, pounds, to develop and even a three- month delay in bringing it to the market has considerable financial considerations. Even worse, failures to fully report all the available data or the release of product bearing incorrect labeling, may easily result in the need for a product recall [11-13]. Either occurrence may lead to the loss of several millions of units of sales, not to mention the resulting reduction in confidence of the investors, health professionals and patients [14]. The Regulatory Affairs department is very often the first point of contact between the government authorities and the company.